No studies have assessed effects of extended use on cancer development risk, fertility, or interaction profiles with common medications in human populations
Acknowledgements This research was funded by the Canadian Institutes of Health Research (CIHR) Project Grant #PJT-153055 to SA Bainbridge and KJ Menzies
Br J Pharmacol 129:17551763 Lovric-Bencic M, Sikiric P, Hanzevacki JS et al (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse
reports research grant support, on behalf of their institution, from Novo Nordisk and advisory/consultancy fees from Boehringer Ingelheim, Eli Lilly & Company, Gila Therapeutics Inc, GLW-01, International Medical Press, Novo Nordisk, Pfizer and ViiV
ICH Q2(R2) states that analytical procedures should be evaluated for characteristics such as specificity, selectivity, range, accuracy, precision, and robustness where applicable [13]
Concurrent high-dose niacin overlapping NAD+ pathway loads warrant clinician review